v
lOMoARcPSD|301 380
v 4
vv
lOMoARcPSD|301 380 4
TESTBANK–LilleysPharmacolo
CanadianHealthCarePractice,4th
(Sealock),
Chapters 1 – 58 | All Chapters
, v
lOMoARcPSD|301 380
v 4
TABLE OF CONTENTS
v v
, v
lOMoARcPSD|301 380
v 4
Chapter 01: Nursing Practice in Canada and Drug Therapy
v v v v v v v v
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
v v v v v v v v v
MULTIPLEvCHOICE
1. Whichvisvavjudgementvaboutvavparticularvpatient’svpotentialvneedvorvproblem?
a. Avgoal
b. Anvassessment
c. Subjectivevdata
d. Avnursingvdiagnosis
ANSWER:v D
Nursingvdiagnosisvisvthevphasevofvthevnursingvprocessvduringvwhichvavclinicalvjudgementvisvmadevaboutvho
hvconditionsvandvlifevprocessesvorvvulnerabilityvforvthatvresponse.
DIF: CognitivevLevel:vKnowledge
2. Thevpatientvisvtovreceivevoralvfurosemidev(Lasix)veveryvday;vhowever,vbecausevthevpatientvisvunablevtovswa
edicationvorally,vasvordered.vThevnursevneedsvtovcontactvthevphysician.vWhatvtypevofvproblemvisvthis?
a. Av“rightvtime”vproblem
b. Av“rightvdose”vproblem
c. Av“rightvroute”vproblem
d. Av“rightvmedication”vproblem
ANSWER:v C
Thisvisvav“rightvroute”vproblem:vthevnursevcannotvassumevthevroutevandvmustvclarifyvthevroutevwithvthevpres
me”vproblemvbecausevthevorderedvfrequencyvhasvnotvchanged.vThisvisvnotvav“rightvdose”vproblemvbecause
nabilityvtovswallow.vThisvisvnotvav“rightvmedication”vproblemvbecausevthevmedicationvorderedvwillvnotvch
DIF: CognitivevLevel:vApplication
3. Thevnursevhasvbeenvmonitoringvthevpatient’svprogressvonvhisvnewvdrugvregimenvsincevthevfirstvdosevandvhas
vpossiblevadverseveffects.vWhatvnursingvprocessvphasevisvthevnursevpractising?
a. Planning
b. Evaluation
c. Implementation
d. Nursingvdiagnosis
ANSWER:v B
Monitoringvthevpatient’svprogressvisvpartvofvthevevaluationvphase.vPlanning,vimplementation,vandvnursingv
byvthisvexample.
DIF: CognitivevLevel:vApplication
4. Thevnursevisvcaringvforvavpatientvwhovhasvbeenvnewlyvdiagnosedvwithvtypev1vdiabetesvmellitus.vWhichvstate
utcomevcriterionvforvthisvpatient?
a. Thevpatientvwillvfollowvinstructions.
b. Thevpatientvwillvnotvexperiencevcomplications.
c. Thevpatientvadheresvtovthevnewvinsulinvtreatmentvregimen.
d. Thevpatientvdemonstratesvsafevinsulinvself-administrationvtechnique.
ANSWER:v D
Havingvthevpatientvdemonstratevsafevinsulinvself-
administrationvtechniquevisvavspecificvandvmeasurablevoutcomevcriterion.vFollowingvinstructionsvandvavo
pecificvcriteria.vAdherencevtovthevnewvinsulinvtreatmentvregimenvisvnotvobjectivevandvwouldvbevdifficultvto
DIF: CognitivevLevel:vApplication
, v
lOMoARcPSD|301 380
v 4
Copyrightv©v2021,vElseviervInc.vAllvrightsvreserved.
lOMoARcPSD|301 380
v 4
vv
lOMoARcPSD|301 380 4
TESTBANK–LilleysPharmacolo
CanadianHealthCarePractice,4th
(Sealock),
Chapters 1 – 58 | All Chapters
, v
lOMoARcPSD|301 380
v 4
TABLE OF CONTENTS
v v
, v
lOMoARcPSD|301 380
v 4
Chapter 01: Nursing Practice in Canada and Drug Therapy
v v v v v v v v
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition
v v v v v v v v v
MULTIPLEvCHOICE
1. Whichvisvavjudgementvaboutvavparticularvpatient’svpotentialvneedvorvproblem?
a. Avgoal
b. Anvassessment
c. Subjectivevdata
d. Avnursingvdiagnosis
ANSWER:v D
Nursingvdiagnosisvisvthevphasevofvthevnursingvprocessvduringvwhichvavclinicalvjudgementvisvmadevaboutvho
hvconditionsvandvlifevprocessesvorvvulnerabilityvforvthatvresponse.
DIF: CognitivevLevel:vKnowledge
2. Thevpatientvisvtovreceivevoralvfurosemidev(Lasix)veveryvday;vhowever,vbecausevthevpatientvisvunablevtovswa
edicationvorally,vasvordered.vThevnursevneedsvtovcontactvthevphysician.vWhatvtypevofvproblemvisvthis?
a. Av“rightvtime”vproblem
b. Av“rightvdose”vproblem
c. Av“rightvroute”vproblem
d. Av“rightvmedication”vproblem
ANSWER:v C
Thisvisvav“rightvroute”vproblem:vthevnursevcannotvassumevthevroutevandvmustvclarifyvthevroutevwithvthevpres
me”vproblemvbecausevthevorderedvfrequencyvhasvnotvchanged.vThisvisvnotvav“rightvdose”vproblemvbecause
nabilityvtovswallow.vThisvisvnotvav“rightvmedication”vproblemvbecausevthevmedicationvorderedvwillvnotvch
DIF: CognitivevLevel:vApplication
3. Thevnursevhasvbeenvmonitoringvthevpatient’svprogressvonvhisvnewvdrugvregimenvsincevthevfirstvdosevandvhas
vpossiblevadverseveffects.vWhatvnursingvprocessvphasevisvthevnursevpractising?
a. Planning
b. Evaluation
c. Implementation
d. Nursingvdiagnosis
ANSWER:v B
Monitoringvthevpatient’svprogressvisvpartvofvthevevaluationvphase.vPlanning,vimplementation,vandvnursingv
byvthisvexample.
DIF: CognitivevLevel:vApplication
4. Thevnursevisvcaringvforvavpatientvwhovhasvbeenvnewlyvdiagnosedvwithvtypev1vdiabetesvmellitus.vWhichvstate
utcomevcriterionvforvthisvpatient?
a. Thevpatientvwillvfollowvinstructions.
b. Thevpatientvwillvnotvexperiencevcomplications.
c. Thevpatientvadheresvtovthevnewvinsulinvtreatmentvregimen.
d. Thevpatientvdemonstratesvsafevinsulinvself-administrationvtechnique.
ANSWER:v D
Havingvthevpatientvdemonstratevsafevinsulinvself-
administrationvtechniquevisvavspecificvandvmeasurablevoutcomevcriterion.vFollowingvinstructionsvandvavo
pecificvcriteria.vAdherencevtovthevnewvinsulinvtreatmentvregimenvisvnotvobjectivevandvwouldvbevdifficultvto
DIF: CognitivevLevel:vApplication
, v
lOMoARcPSD|301 380
v 4
Copyrightv©v2021,vElseviervInc.vAllvrightsvreserved.
